June 2015, Vol 5, No 5

It is a fact of life. The current tax system rewards taxpayers who are aggressive with their deductions. To find out what people are deducting, we undertook an informal survey of many of our colleagues who are certified public accountants. Read More ›

Pathways versus Personalized Medicine

By Gail Thompson

Personalized Medicine, AVBCC Summit Highlights

By Sheryl A. Riley, RN, OCN, CMCN

Side-Effects Management

The goal of cancer treatment is to destroy cancer cells, whether through surgery, radiation, drug therapies, or a combination of these. During the course of these treatments, however, healthy cells can also be damaged or destroyed, leading to unpleasant side effects such as electrolyte imbalance, dehydration, weight loss, fatigue, infection, lack of appetite, mouth sores, skin irritations, anemia, and depression. Read More ›

Insurance Status Linked to Higher Rates of Certain Cancer Types

By Rosemary Frei, MSc

By Dawn Holcombe, MBA, FACMPE, ACHE

From the Editor

By Rosemary Frei, MSc

Reimbursement

According to a recent study, 63.6% of oncologists surveyed favor the establishment of an independent panel of health experts to decide which treatments Medicare will pay for based on a cost-benefit analysis (Gogineni K, et al. J Clin Oncol. 2015;33:846-853). Less than 50% of patients and members of the general public think this is a good idea. The United Kingdom’s National Institute for Health and Care Excellence (NICE) is one model for such a panel. Read More ›

Future of Patient Support Services Offers Challenges, Opportunities

By Rosemary Frei, MSc

By Ruth Linn Lander, FACMPE

Practice Management

SGR Is Over: What’s Next for Providers?

By Maureen Leddy, JD

Clinical Trials Tracker